Search - tctmd.com

Displaying 201 - 220 of 236

Sort: Relevancy | Date

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Robert Whitbourn

October 29, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives I

Presenter: Antonio Colombo

October 27, 2013

Presentation TCT 2013

The ABSORB III trial: Design, Goals and Enrollment Status

Presenter: Stephen Ellis

October 27, 2013

Presentation TCT 2013

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Presenter: Richard Rapoza

October 27, 2013

Presentation TCT 2013

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

Presentation TCT 2013

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Presenter: Peter Smits

October 27, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives II

Presenter: Robert-Jan van Geuns

October 27, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

Presentation

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

Presenter: 53632|Koen Nieman

August 07, 2013

Presentation

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

Presenter: 53632|Koen Nieman

August 07, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Daily News

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

March 25, 2013

Advertisement

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Is ABSORB a Workhorse DES? Real-world Perspectives I

The ABSORB III trial: Design, Goals and Enrollment Status

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Latest Results from ABSORB Extend: Comparison with Xience

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Is ABSORB a Workhorse DES? Real-world Perspectives II

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content